The Cigna Group Implements Strategic Change with Dr. Amy Flaster as Chief Medical Officer

Cigna Appoints Dr. Amy Flaster as Chief Medical Officer

On November 1, 2025, The Cigna Group made a significant announcement, appointing Dr. Amy Flaster as their new Chief Medical Officer. This strategic move is designed to strengthen Cigna’s commitment to improving healthcare delivery and enhancing the overall health of millions of patients globally. Dr. Flaster, who previously served as the Chief Medical Officer for Cigna Healthcare, will now expand her role across both Cigna Healthcare and Evernorth, the company’s health services segment.

A Leader in Innovative Healthcare Solutions

Dr. Flaster brings to her new position a wealth of experience in health management and clinical operations. Her career trajectory is marked by her innovative approach and strategic thinking in patient care. "Dr. Flaster is a proven strategic and innovative leader with extensive experience in patient care, technology, and hospital leadership," expressed David M. Cordani, CEO of The Cigna Group.

As she transitions into this expanded role, Dr. Flaster aims to promote clinical excellence by developing innovative care models, enhancing clinical teams, and utilizing technology to support whole-person health—an approach focused on treating the individual rather than just their illness.

Since her arrival at Cigna, she has been instrumental in implementing clinical programs that have significantly improved health outcomes and cost-efficiency for customers. Her leadership in areas such as integrated care, behavioral health, and digital health innovation is helping reshape the way Cigna approaches healthcare.

Continuing the Journey of Transformation

Dr. Flaster's promotion comes at a pivotal time for Cigna, as they actively seek to revolutionize health service models. Her background as a practicing primary care physician at Brigham and Women's Hospital in Boston adds a unique perspective to her role, ensuring that patient concerns remain central to decision-making processes.

Additionally, Katya Andresen, Chief Digital & Analytics Officer, is taking the lead on the Cigna Group's Excellence and Transformation initiatives, which are designed to improve customer engagement and foster innovation across all platforms. Those initiatives emphasize creating a more personalized and human-centered experience for users navigating healthcare services.

A Shift in Leadership

Dr. Flaster's promotion coincides with the departure of Dr. David Brailer, former Executive Vice President and Chief Health Officer, who played a crucial role in advancing Cigna's clinical strategies and improving access to healthcare. Furthermore, Chris DeRosa, the Head of Business Improvement and Innovation, is set to retire after two decades, marking the end of an era at Cigna.

The company's history of transformative health initiatives showcases its commitment to improving the quality and accessibility of care worldwide. As they move forward, Dr. Flaster’s leadership is expected to drive significant advancements in healthcare delivery, further reinforcing Cigna's reputation as a leader in the global health market.

A Commitment to a Better Future

The Cigna Group continues to position itself as a trailblazer in the health industry, focusing on better health outcomes at every level of care. By promoting leaders like Dr. Flaster who are passionately committed to enhancing patient care, Cigna aims to generate meaningful change in the healthcare landscape.

For further updates on The Cigna Group's initiatives and leadership developments, visit their official website. Their commitment to fostering innovation and collaboration in health services promises a bright future for their global customer base.